Dianthus Therapeutics, Inc. (DNTH)

Insiders sold $71.2M in the past 12 months, 100% under disclosed plans; their starting stakes can't be measured from the filings. Why

Latest filing: Filed Sep 18 for a sale on Sep 17. Edward Carr sold 20K shares ($2.0M) under a disclosed plan. Filing